Ketoconzole dosage and administration

Revision as of 21:41, 8 January 2014 by Ahmed Zaghw (talk | contribs) (Created page with "__NOTOC__ {{Ketoconazole}} {{CMG}}; {{AE}} {{AZ}} '''Dosage and Administration''' There should be laboratory as well as clinical documentation of infection prior to starting...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Ketoconzole
Ketoconazole® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Dosage and Administration

There should be laboratory as well as clinical documentation of infection prior to starting ketoconazole therapy. The usual duration of therapy for systemic infection is 6 months. Treatment should be continued until active fungal infection has subsided.[1]

References

  1. "KETOCONAZOLE TABLET [TARO PHARMACEUTICALS U.S.A., INC.]".

Adapted from the FDA Package Insert.